United States The infant formula factory is reopening in the United States in the midst of a shortage

It is hoped that reopening will alleviate the lack of substitutes. The plant, which is closed due to bacterial infections, is ready to open during June.

American Abbott Nutrition announced on Saturday the reopening of its infant formula plant in Sturgis, Michigan. The continued operation of the plant will alleviate the shortage of substitutes suffered by the United States. They reported Reuters and The Washington Post.

The shortage of substitutes has caused panic in many parents who need substitutes for their children. According to Reuters, in the United States, less than half of babies are fed during the first three months of breastfeeding alone.

The plant is scheduled to continue operations on June 20. The U.S. Food and Drug Administration (FDA) said on May 19 that the plant would be ready to open in two weeks.

The facility will be opened once it meets FDA-agreed requirements, Abbott said.

“We understand the urgent need for a substitute, and our top priority is to have a high-quality and safe substitute for families across America,” Abbott said in a statement.

See also  HS Environment | Timo Hämäläinen became interested in an everyday phenomenon in Helsinki: Empty space is everywhere as unused "little deserts"

About 73 percent of the replacement products sold out on May 22, according to Datasembly in the United States.

Factory was closed at the beginning of the year following the FDN’s inspection of unhygienic conditions, which exacerbated the shortage of substitutes caused by supply chain problems that began with the coronavirus pandemic.

A plant inspection in February was carried out after four babies who had received a factory-made substitute were diagnosed with a bacterial infection. Two of the babies died as a result of the infection.

Abbott has said the infections cannot be proven to have come from surrogates. Inspectors found bacteria in the environment but not in the product itself. The FDA and Abbott signed an agreement to upgrade the plant.

Even after the factory reopens, it can take up to weeks for substitute production to return to normal, an FDA official said. Robert Califf Has said.

#United #States #infant #formula #factory #reopening #United #States #midst #shortage

Related Posts

Next Post

Leave a Reply

Your email address will not be published. Required fields are marked *

Recommended